Factors of Risk in the Development of Coronary Heart Disease—Six-Year Follow-up Experience

doi:10.1059/0003-4819-55-1-33

Factors of Risk in the Development of Coronary Heart Disease—Six-Year Follow-up Experience

WILLIAM B. KANNEL, M.D.;
THOMAS R. DAWBER, M.D., F.A.C.P.;
ABRAHAM KAGAN, M.D., F.A.C.P.;
NICHOLAS REVOTSKIE, M.D.; and
JOSEPH STOKES III, M.D.

Requests for reprints should be addressed to Thomas R. Dawber, M.D., F.A.C.P., Medical Director, Heart Disease Epidemiology Study,
25 Evergreen St., Framingham, Mass.

References

1.
1. DAWBER T. R.,
2. MOORE F. E., JR.,
3. MANN G. V.
: II. Coronary heart disease in the Framingham Study. Amer. J. Public Health 47: 4, 1957.
FREE Full Text
2.
1. DAWBER T. R.,
2. MEADORS G. F.,
3. MOORE F. E., JR.
: Epidemiological approaches to heart disease: the Framingham Study. Amer. J. Public Health 41: 279, 1951.
FREE Full Text
3.
1. DAWBER T. R.,
2. MOORE F. E.
: Longitudinal study of heart disease in Framingham, Massachusetts. An interim report: research in public health. 1951 Annual Conference of the Milbank Memorial Fund. Milbank Mem. Fund Quart. 1952.
4.
1. DAWBER T. R.,
2. KANNEL W. B.
: An epidemiological study of heart disease: the Framingham Study. Nutr. Rev. 16: 1, 1958.
Medline Web of Science
5.
1. GORDON T.,
2. MOORE F. E., JR.,
3. SHURTLEFF D.,
4. DAWBER T. R.
: Some methodologic problems in the long-term study of cardiovascular disease: observations on the Framingham Study. J. Chron. Dis. 10: 186, 1959.
CrossRef
6.
1. DAWBER T. R.,
2. KANNEL W. B.,
3. REVOTSKIE N.,
4. STOKES J., III,
5. KAGAN A.,
6. GORDON T.
: Some factors associated with the development of coronary heart disease. Six years' follow-up experience in the Framingham Study. Amer. J. Public Health 49: 1349, 1959.
FREE Full Text
7.

Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Blood Vessels, Criteria Committee of the N. Y. Heart Association, 5th Ed., New York, 1953.
8.
1. ABELL L. L.,
2. LEVY B. B.,
3. BRODIE B. B.,
4. KENDALL F. E.
: A simplified method for the estimation of total cholesterol in serum and the demonstration of its specificity. J. Biol. Chem. 195: 357, 1952.
FREE Full Text
9.
1. TECHNICAL GROUP, COMMITTEE ON LIPOPROTEINS AND ATHEROSCLEROSIS OF THE NATIONAL ADVISORY HEART COUNCIL
: An evaluation of serum lipoproteins and cholesterol measurements as predictors of clinical complications of atherosclerosis: a report of a cooperative study of lipoproteins and atherosclerosis. Circulation 14: 691, 1956.
Medline Web of Science
10.
1. FRIEDBERG C. K.
: Diseases of the Heart, 2nd Ed., W. B. Saunders Company, Philadelphia, 1956, p. 455.
11.
1. FRIEDBERG C. K.
: Diseases of the Heart, 2nd Ed., W. B. Saunders Company, Philadelphia, 1956, pp. 317, 433, 543.
12.
1. DOYLE J. T.,
2. HESLIN S. A.,
3. HILLEBOE H. E.,
4. FORMEL P. F.,
5. KORNS R. F.
: A prospective study of degenerative cardiovascular disease in Albany: report of three years' experience. I. Ischemic heart disease. Amer. J. Public Health 47: 25, 1957.
FREE Full Text
13.
1. CHAPMAN J. M.,
2. GOERKE L. S.,
3. DIXON W.,
4. LOVELAND D. B.,
5. PHILLIPS E.
: The clinical status of a population group in Los Angeles under observation for two to three years. Amer. J. Public Health 47: 43, 1957.
FREE Full Text
14.
1. CORNFIELD J.,
2. GORDON T.,
3. SMITH W.
: Quantal response curves for experimentally uncontrolled variables. Proceedings of the 32nd Session of the International Statistical Institute, Tokyo, 1960. To be published.

Article and Author Information

Received for publication April 19, 1961.
From the Heart Disease Epidemiology Study, Framingham, Mass., and the National Heart Institute, National Institutes of Health, Public Health Service, U. S. Department of Health, Education, and Welfare, Washington, D. C.

[1] 1.

DAWBER T. R.,

MOORE F. E., JR.,

MANN G. V.

: II. Coronary heart disease in the Framingham Study. Amer. J. Public Health 47: 4, 1957.

FREE Full Text

[2] DAWBER T. R.,

[3] MOORE F. E., JR.,

[4] MANN G. V.

[5] 2.

DAWBER T. R.,

MEADORS G. F.,

MOORE F. E., JR.

: Epidemiological approaches to heart disease: the Framingham Study. Amer. J. Public Health 41: 279, 1951.

FREE Full Text

[6] DAWBER T. R.,

[7] MEADORS G. F.,

[8] MOORE F. E., JR.

[9] 3.

DAWBER T. R.,

MOORE F. E.

: Longitudinal study of heart disease in Framingham, Massachusetts. An interim report: research in public health. 1951 Annual Conference of the Milbank Memorial Fund. Milbank Mem. Fund Quart. 1952.

[10] DAWBER T. R.,

[11] MOORE F. E.

[12] 4.

DAWBER T. R.,

KANNEL W. B.

: An epidemiological study of heart disease: the Framingham Study. Nutr. Rev. 16: 1, 1958.

Medline Web of Science

[13] DAWBER T. R.,

[14] KANNEL W. B.

[15] 5.

GORDON T.,

MOORE F. E., JR.,

SHURTLEFF D.,

DAWBER T. R.

: Some methodologic problems in the long-term study of cardiovascular disease: observations on the Framingham Study. J. Chron. Dis. 10: 186, 1959.

CrossRef

[16] GORDON T.,

[17] MOORE F. E., JR.,

[18] SHURTLEFF D.,

[19] DAWBER T. R.

[20] 6.

DAWBER T. R.,

KANNEL W. B.,

REVOTSKIE N.,

STOKES J., III,

KAGAN A.,

GORDON T.

: Some factors associated with the development of coronary heart disease. Six years' follow-up experience in the Framingham Study. Amer. J. Public Health 49: 1349, 1959.

FREE Full Text

[21] DAWBER T. R.,

[22] KANNEL W. B.,

[23] REVOTSKIE N.,

[24] STOKES J., III,

[25] KAGAN A.,

[26] GORDON T.

[27] 7.

Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Blood Vessels, Criteria Committee of the N. Y. Heart Association, 5th Ed., New York, 1953.

[28] 8.

ABELL L. L.,

LEVY B. B.,

BRODIE B. B.,

KENDALL F. E.

: A simplified method for the estimation of total cholesterol in serum and the demonstration of its specificity. J. Biol. Chem. 195: 357, 1952.

FREE Full Text

[29] ABELL L. L.,

[30] LEVY B. B.,

[31] BRODIE B. B.,

[32] KENDALL F. E.

[33] 9.

TECHNICAL GROUP, COMMITTEE ON LIPOPROTEINS AND ATHEROSCLEROSIS OF THE NATIONAL ADVISORY HEART COUNCIL

: An evaluation of serum lipoproteins and cholesterol measurements as predictors of clinical complications of atherosclerosis: a report of a cooperative study of lipoproteins and atherosclerosis. Circulation 14: 691, 1956.

Medline Web of Science

[34] TECHNICAL GROUP, COMMITTEE ON LIPOPROTEINS AND ATHEROSCLEROSIS OF THE NATIONAL ADVISORY HEART COUNCIL

[35] 10.

FRIEDBERG C. K.

: Diseases of the Heart, 2nd Ed., W. B. Saunders Company, Philadelphia, 1956, p. 455.

[36] FRIEDBERG C. K.

[37] 11.

FRIEDBERG C. K.

: Diseases of the Heart, 2nd Ed., W. B. Saunders Company, Philadelphia, 1956, pp. 317, 433, 543.

[38] FRIEDBERG C. K.

[39] 12.

DOYLE J. T.,

HESLIN S. A.,

HILLEBOE H. E.,

FORMEL P. F.,

KORNS R. F.

: A prospective study of degenerative cardiovascular disease in Albany: report of three years' experience. I. Ischemic heart disease. Amer. J. Public Health 47: 25, 1957.

FREE Full Text

[40] DOYLE J. T.,

[41] HESLIN S. A.,

[42] HILLEBOE H. E.,

[43] FORMEL P. F.,

[44] KORNS R. F.

[45] 13.

CHAPMAN J. M.,

GOERKE L. S.,

DIXON W.,

LOVELAND D. B.,

PHILLIPS E.

: The clinical status of a population group in Los Angeles under observation for two to three years. Amer. J. Public Health 47: 43, 1957.

FREE Full Text

[46] CHAPMAN J. M.,

[47] GOERKE L. S.,

[48] DIXON W.,

[49] LOVELAND D. B.,

[50] PHILLIPS E.

[51] 14.

CORNFIELD J.,

GORDON T.,

SMITH W.

: Quantal response curves for experimentally uncontrolled variables. Proceedings of the 32nd Session of the International Statistical Institute, Tokyo, 1960. To be published.

[52] CORNFIELD J.,

[53] GORDON T.,

[54] SMITH W.

Factors of Risk in the Development of Coronary Heart Disease—Six-Year Follow-up Experience

References

Article and Author Information

This Article

Services

Rapid Responses

Citing Articles

Google Scholar

PubMed

Related Content

Social Bookmarking

Current Issue

Features

Info for Users

Annals in the News

Most Read

Clinical Trials

Classifieds